Pfizer Applies for EUA for its Oral COVID-19 Treatment, Inks Deal with Medicines Patent Pool

Pfizer has filed its application with the FDA for Emergency Use Authorization (EUA) of its investigational oral antiviral candidate, Paxlovid, for the treatment of mild-to-moderate COVID-19 in patients at increased risk of hospitalization or death.
Source: Drug Industry Daily